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Correction to: the role of the complement
system in traumatic brain injury: a review
Adnan Hammad1, Laura Westacott2 and Malik Zaben2*
Correction
After publication of the article [1], it was brought to our
attention that Tables 1 and 2 were missing from the final
manuscript, These tables can be seen below and have
now been added to the revised version of the article.
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Table 1 Summary of clinical studies investigating the role of complement in TBI
Study Type of brain
insult
Controls Assay Complement
pathway(s)
Relevant finding(s)
Bellander et al.,
2001 [23]
Cerebral
contusion (n=16)
Epileptic patients undergoing
hippocampectomy (n=3)
Immunohistochemistry
(IHC) for C1q, C3b, C3d
and MAC; in situ
hybridization for C3 mRNA
All Increased immunoreactivity for
C1q, C3b, C3d and the MAC
in the immediate vicinity of
neurons in the penumbra area
of the contusion in the patient
group. In situ hybridization
revealed C3 mRNA in the
penumbra.
Kossmann et al.,
1997 [74]
Severe TBI (n=13):
closed head injury
(n=12); open head
injury (n=1)
Patients undergoing
diagnostic lumbar
puncture (n=22)
Radioimmunoassay
(RIA) or enzyme linked
immunosorbent assay
(ELISA) for C3 and fB
All Elevated levels of C3 and fB in
CSF of TBI patients compared
to controls.
Stahel et al.,
2001 [24]
Severe TBI (closed
head injury) (n=11)
Patients, without any
known head trauma or
inflammatory neurological
disease, undergoing
diagnostic spinal
tap (n=12)
ELISA for sC5b-9 All Raised mean sC5b-9 levels in
CSF of 10 out of 11 TBI patients
compared to CSF obtained from
controls.
Longhi et al.,
2014 [75]
Cerebral contusion
(n=6)
Non-TBI patients who
received surgery for
brain tumors (n=2)
IHC for MBL Lectin MBL-positive staining was
observed in brain tissue samples
from cerebral contusion patients,
but not in equivalent samples
from controls.
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Table 2 Summary of studies investigating the role of complement in TBI using animal models
Study Species Model Treatment Complement
pathway(s)
Relevant finding(s)
Kaczorowski
et al., 1995 [79]
Rat Standardized
weight-drop
• WT + sCR1
• WT + vehicle
All Rats treated with sCR1 had reduced brain
neutrophil infiltration compared to vehicle-
treated rats, suggesting that complement plays
a role in the neuroinflammatory response
induced by TBI.
Yang et al.,
2006 [80]
Mouse Intracerebral
hemorrhage (ICH)
• C3-/-
• WT
All C3-/- mice, when compared with WT mice,
showed reduced brain oedema, lower
hemeoxygenase-1 levels, and reduced microglia
activation and neutrophil infiltration after injury.
The C3-/- mice also displayed reduced forelimb
dysfunction in comparison with WT mice.
Sewell et al.,
2004 [81]
Mouse Cryoinjury • C3-/-
• C5-/-
• WT + C5aR antagonist
• WT
All Injury size and neutrophil infiltration were
significantly reduced in C3-/- mice compared
with WT mice. Neutrophil infiltration was also
found to be reduced in C5-/- mice and WT mice
treated with a C5aR antagonist compared with
untreated WT mice.
Rancan et al.,
2003 [83]
Mouse Standardized
weight-drop model
(focal closed head injury)
• GFAP-sCrry
• WT
All GFAP-sCrry mice were found to have reduced
neurological deficits and BBB compromise
compared with WT mice exposed to the same
TBI-like injury.
Leinhase et al.,
2006a [84]
Mouse Standardized
weight-drop
• WT + Crry-Ig
• WT + vehicle
All Administration of Crry-Ig 1 and 24 hrs after
injury was associated with a reduction in tissue
loss and improvement in neurological function
when compared with vehicle-treated mice.
Garrett et al.,
2009 [85]
Mouse ICH • WT + C5aR antagonist
• WT + C5aR
antagonist + C3aR antagonist
• WT + vehicle
All Administration of a C5aR antagonist alone, or
both C5aR and C3aR antagonists, to WT mice
was associated with a reduced deficit in
neurological function and reduced spatial
memory dysfunction compared with vehicle-
treated WT mice. These effects were also
associated with a reduction in leukocyte
infiltration and oedema A synergistic effect was
observed upon administration of both
antagonists.
Stahel et al.,
2009 [88]
Mouse Standardized weight-drop • CD59a-/-
• WT
All CD95a-/- mice had significantly worse
neurological outcomes than WT mice 7 days
post-injury. Neuronal cell death in CD59a-/- mice
was also greater than that in WT mice, as
indicated both by serum NSE levels as well as
TUNEL histochemistry.
Fluiter et al.,
2014 [89]
Mouse Standardized weight-drop • WT + OmCI
• WT + C6 antisense
• WT + vehicle
All Interfering with MAC formation, by
administering OmCI or C6 antisense to WT mice,
was associated with a reduction in neuronal
death, microglial activation and neurological
deficit, compared with vehicle-treated WT mice.
Ruseva et al.,
2015 [90]
Mouse Standardized
weight-drop
• WT + CD59-2a-CRIg
• WT + vehicle
All CD59-2a-CRIg was found to inhibit MAC
formation in vitro. In vivo administration of CD59
-2a-CRIg reduced MAC formation, neuronal
damage, and microglial activation compared to
vehicle treated controls. Neurological outcomes
were ameliorated with CD59-2a-CRIg
administration.
Leinhase et al.,
2006b [91]
Mouse Standardized
weight-drop
• fB-/-
• WT
Alternative fB-/- mice were found to have reduced neuronal
loss, upregulation of the anti-apoptotic
regulatory protein Bcl-2, and downregulation of
the pro-apoptotic Fas receptor, compared with
WT mice subsequent to a TBI-like injury.
Leinhase et al.,
2007 [92]
Mouse Standardized
weight-drop
• WT + mab1379
• WT
Alternative Administration of mab1379, a monoclonal
antibody directed against fB, 1 or 24 hrs after
injury was associated with reduced neuronal
loss, an attenuated inflammatory
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Table 2 Summary of studies investigating the role of complement in TBI using animal models (Continued)
Study Species Model Treatment Complement
pathway(s)
Relevant finding(s)
response, as well as upregulation of genes
associated with neuroprotection, in comparison
with vehicle administration.
You et al.,
2007 [82]
Mouse Controlled
cortical impact (CCI)
• C3-/-
• C4-/-
• C4-/- + hC4
• WT
• All (C3)
• Classical
and lectin (C4)
C3-/- mice were found to have reduced brain
leukocyte infiltration compared to WT, but there
were no differences between them in terms of
injury size or neurological deficits. C4-/- mice
showed decreased brain tissue damage and
reduced motor deficits, compared to WT, after
CCI. These improvements were reversed if
recombinant human C4 (hC4) was administered
to C4-/- mice.
Longhi et al.,
2009 [93]
Mouse CCI • WT + C1-INH
• WT
Classical and
lectin
Mice given C1-INH 10 mins after injury
developed smaller contusions, and had reduced
cognitive and motor dysfunction compared to
vehicle-treated controls. Delayed administration
of C1-INH (60 mins post-injury) led to a
reduction in motor dysfunction, but had no
effect on cognitive deficits or contusion size.
Longhi et al.,
2014 [75]
Mouse CCI • MBL-/-
• WT
Lectin MBL-C and MBL-A immunostaining was
upregulated 30 mins post-injury, and this lasted
for a week. MBL-A immunostaining was less
prominent. Neuronal loss in MBL-A/MBL-C
knockout (MBL-/-) mice was reduced when
compared with wildtypes 5 weeks post-injury,
which was paralleled by a reduction in
sensorimotor impairment when assessed 2-4
weeks post-lesion.
Yager et al.,
2008 [94]
Mouse CCI • MBL-/-
• WT
Lectin 6 hrs post-injury, increased neurodegeneration
was observed in the hippocampi of MBL-/- mice
when compared with WT mice. Neurological
deficits in MBL-/- mice were also greater than
those in WT mice, when assessed a week after
injury.
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